sTREM-1 as a Predictive Biomarker for Disease Severity and Prognosis in COVID-19 Patients.

sTREM-1 demonstrated good predictive value for disease severity and 28-day mortality, serving as an independent prognostic factor for adverse patient outcomes. In the future, we anticipate conducting large-scale multicenter studies to validate our research findings.